Alprostadil and Cobamamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alprostadil (alprostadil) and Cobamamide (dibencozide). Common drug interactions include abdominal distension among females and blood urea increased among males.

The phase IV clinical study analyzes what interactions people have when they take Alprostadil and Cobamamide. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Alprostadil?

Alprostadil has active ingredients of alprostadil. It is often used in erection problems. eHealthMe is studying from 2,653 Alprostadil users. Check the latest studies of Alprostadil.

What is Cobamamide?

Cobamamide has active ingredients of dibencozide. eHealthMe is studying from 1,046 Cobamamide users. Check the latest studies of Cobamamide.

On Jul, 25, 2026

17 people who take Alprostadil and Cobamamide together, and have interactions are studied.

Alprostadil and Cobamamide drug interactions.

What are the common drug interactions of Alprostadil and Cobamamide, by gender? *:

female:

Abdominal distension
Anaemia (lack of blood)
Bilirubin conjugated increased
Blood glucose increased
Blood urea increased
Haemoglobin decreased
Lymphocyte count decreased
Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
Pancreatitis (inflammation of pancreas)
Platelet count decreased

male:

Blood urea increased
Haemoglobin decreased
Bilirubin conjugated increased
Blood cholesterol decreased
Kidney transplant rejection
Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues)
Proteinuria (presence of protein in the urine)
Renal failure (kidney dysfunction)
Protein urine present
Abdominal discomfort

What are the common drug interactions of Alprostadil and Cobamamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Blood urea increased
Haemoglobin decreased
Glomerular filtration rate decreased
Anaemia (lack of blood)
Blood glucose increased
Incision site pain
Lymphocyte count decreased
Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
Urinary tract infection
Abdominal distension

40-49:

Lymphocyte count decreased
Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
Pancreatitis (inflammation of pancreas)
Platelet count decreased
White blood cell count increased
Abdominal distension
Anaemia (lack of blood)
Bilirubin conjugated increased
Blood glucose increased
Blood urea increased

50-59:

Meningitis cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)

60+:

Lung infection
Plasma cell myeloma (cancer that begins in plasma cells)
Chronic kidney disease

What are the existing conditions these people have? *

Anaemia (lack of blood): 14 people, 82.35%
High Blood Pressure: 14 people, 82.35%
Urination - Excessive Volume: 10 people, 58.82%
Red Blood Cell Count Decreased: 10 people, 58.82%
Vasospasm (sudden constriction of a blood vessel, reducing its diameter and flow rate): 10 people, 58.82%
Heart Disease: 8 people, 47.06%
Hypotension (abnormally low blood pressure): 8 people, 47.06%
Lipids Increased (excess lipid in body): 8 people, 47.06%
Diarrhea: 6 people, 35.29%
Haemostasis (stopping of bleeding): 6 people, 35.29%

* Approximation only. Some reports may have incomplete information.

Do you take Alprostadil and Cobamamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously